Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 454

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 454
---
 stock swap transaction. OSR Holdings also acquired the remaining 7.87% of Vaximm’s outstanding equity through two subsequent transactions: (1) on January 19, 2023, OSR Holdings exercised an option to acquire the 4.89%, or 38,909shares, of Vaximm held by BCME, by exchanging 1,750 BCME preference shares held by OSR Holdings; and (2) on February 2, 2023, OSR Holdings purchased 23,656shares (2.98%) of Vaximm held by BCME for $3.6 million in cash. In September 2022, OSR Holdings invested KRW 97,742,345 for a 33% interest in Taction Co., Ltd., a Korean software development and consulting firm. Taction has ceased operations and has no practical plan to generate revenue; OSR Holdings has recognized impairment loss amounting to its acquisition cost. On December 26, 2022, OSR Holdings acquired all of the outstanding shares of RMC Co., Ltd., a South Korean neuro -interventionmedical device distributor. OSR Holdings issued 70,847shares of OSR Holdings’ common stock to the sole shareholder of RMC, Mr. Chan Kyu Park, the founder and CEO of RMC, and also a minority shareholder of OSR Holdings. On March 31, 2023, OSR Holdings acquired all of the outstanding shares of Darnatein, an Incheon, South Korea -basedcorporation that is developing therapies for age -relatedand degenerative diseases and their associated chronic disorders and complications. OSR Holdings issued to the stockholders of Darnatein 590,425shares of OSR Holdings’ common stock. On a consolidated basis, OSR Holdings has funded its operations primarily through the issuance of common shares, convertible preferred shares, convertible bonds and loans. As of June 30, 2024, on a consolidated basis, OSR Holdings has raised a cumulative KRW 11.64 billion in gross proceeds through the issuance of common shares, convertible preferred shares and debt (including bank loans of KRW 443.25 million made to RMC). In addition, during 2024, OSR executed (a) loan agreements permitting it to borrow an aggregate of $1.1 million from its affiliate BCME consisting of the following individual loans: (1) $50,000 due February 21, 2025 (repaid in